When the Bladder Sends Mixed Signals: Coexistence of Overactive Bladder and Urinary Retention in Palliative Care
In palliative medicine, attention to genitourinary symptoms is often overshadowed by more pressing issues such as pain, dyspnea, or existential distress. Yet lower urinary tract dysfunction—particularly the confusing coexistence of overactive bladder (OAB) symptoms and urinary retention—is both common and under-recognized, especially in older adults with complex comorbidities. Understanding this paradoxical presentation is crucial for improving comfort, dignity, and quality of life in the patients we serve.
The Bladder’s Dual Role: Storage and Emptying
The bladder functions as both a reservoir and a pump. During the storage phase, the detrusor muscle remains relaxed while the urethral sphincters maintain closure. When the bladder reaches a certain volume, afferent signals trigger the urge to void, followed by coordinated detrusor contraction and sphincter relaxation. Disruption of this finely tuned mechanism—whether from neurodegeneration, obstruction, medications, or aging—can result in a complex array of symptoms.
Overactive bladder (OAB) refers to involuntary detrusor contractions that occur during the filling phase, leading to urgency, frequency, nocturia, and often urge incontinence. In contrast, urinary retention arises when the bladder is unable to generate an effective contraction or when outflow is obstructed, resulting in incomplete emptying or, in some cases, an atonic bladder.
While OAB and urinary retention may seem mutually exclusive, they frequently coexist. This phenomenon, known in urological circles as detrusor overactivity with impaired contractility (DOIC), is particularly relevant in palliative populations.
Pathophysiologic Mechanisms Behind the Dual Dysfunction
Several mechanisms may contribute to simultaneous storage and voiding dysfunction:
1. Neurologic Disorders: Conditions such as Parkinson’s disease, multiple sclerosis, vascular dementia, or spinal cord injury may disrupt the central or peripheral nervous control of the bladder. This can lead to both uncontrolled detrusor activity and failure to generate an effective voiding contraction.
2. Outlet Obstruction: In men with benign prostatic hyperplasia (BPH), chronic obstruction may initially trigger compensatory bladder hypertrophy and instability (causing urgency and frequency). Over time, the detrusor muscle fatigues and decompensates, leading to post-void residuals and retention.
3. Aging Bladder: The aging bladder often exhibits decreased compliance, reduced sensation, impaired contractility, and increased involuntary contractions. The end result is a “confused bladder” that both overreacts and underperforms.
4. Polypharmacy and Sedation: Many medications used in palliative care—including opioids, anticholinergics, and benzodiazepines—can suppress bladder contractility, inhibit sensation of fullness, or increase outflow resistance. Even while patients report urinary urgency, their ability to void may be impaired by pharmacologic effects.
Clinical Implications in Palliative Settings
For patients receiving palliative care, urinary symptoms can be deeply distressing. Urgency and incontinence erode autonomy and dignity, while retention can lead to discomfort, recurrent urinary tract infections, bladder overdistension, and even urosepsis.
The challenge is compounded by communication barriers in patients with advanced dementia or delirium. These individuals may be unable to express the sensation of incomplete emptying or urgency. Instead, they exhibit agitation, restlessness, or refusal to sit on the commode—behaviors sometimes misinterpreted as psychiatric in origin.
Moreover, catheterization decisions become ethically complex. While indwelling catheters may relieve retention and protect the skin from incontinence-associated dermatitis, they can also cause discomfort, infection, or restrict mobility. We must balance goals of care with pragmatic symptom relief, always centering the patient’s comfort.
Assessment Tools and Diagnostic Considerations
Formal urodynamic testing is rarely feasible or appropriate in palliative care settings. Instead, we rely on a thorough clinical assessment:
- History: Ask about frequency, urgency, hesitancy, straining, dribbling, and nocturia. Note any recent changes in mobility, cognition, or fluid intake.
- Bladder Scan: Portable ultrasound can non-invasively assess post-void residuals (PVR). A PVR >150-200 mL may indicate significant retention.
- Physical Exam: Palpate for suprapubic fullness. Inspect for perineal hygiene issues, skin breakdown, or signs of infection.
- Review Medications: Opioids, anticholinergics, muscle relaxants, and even calcium channel blockers can contribute to urinary dysfunction.
Management Strategies
The coexistence of OAB and retention creates a therapeutic paradox: treatments for one often exacerbate the other. Anticholinergic agents like oxybutynin may reduce urgency but worsen retention. Conversely, alpha-blockers or catheterization can relieve retention but fail to address urgency and leakage. As such, a tailored and cautious approach is warranted.
Conservative Measures:
- Encourage timed voiding or scheduled toileting every 2–3 hours to reduce bladder overdistension.
- Utilize incontinence pads or bedside commodes to preserve independence and reduce falls.
- Consider pelvic floor therapy, if appropriate and feasible.
Pharmacologic Caution:
- Use bladder relaxants (e.g., mirabegron or low-dose anticholinergics) sparingly and only if retention is minimal.
- Avoid unnecessary anticholinergic burden in patients with dementia or significant cognitive impairment.
Catheterization:
- Intermittent catheterization may be preferable to indwelling Foley catheters, particularly in patients with meaningful mobility and limited retention.
- For end-of-life comfort, an indwelling catheter may provide consistent relief and minimize incontinence-related distress.
- In terminal agitation or skin breakdown, the benefits of catheter placement often outweigh the risks.
Reframing Goals of Care
As always in palliative care, management decisions should reflect the patient’s goals, prognosis, and overall condition. In some cases, it may be reasonable to tolerate higher PVRs or mild incontinence if these do not cause discomfort. In others, small interventions such as reducing nighttime fluids or simplifying the medication list can dramatically improve quality of life.
Importantly, we must also support caregivers. The emotional and physical toll of managing unpredictable urinary symptoms at home is substantial. Clear communication, education, and the offer of practical supports—such as commode chairs, urinals, or incontinence supplies—can ease the burden.
Conclusion
The coexistence of overactive bladder and urinary retention illustrates the complexity of caring for aging and terminally ill patients. These are not “either-or” conditions but rather expressions of a bladder under stress—whether from disease, medication, or aging. Palliative care professionals are uniquely positioned to recognize and respond to these symptoms with sensitivity, creativity, and a focus on comfort.
Urinary symptoms may not be life-threatening, but in the eyes of a patient confined to bed, wearing a pad, or unable to void without pain or shame, they matter immensely. Addressing them thoughtfully is an act of respect, compassion, and clinical excellence.
References:
- Walton, Abigail. Managing Overactive Bladder Symptoms in a Palliative Care Setting. Journal of Palliative Medicine 2014 17:1, 118-121.
- Nabi G, Cody JD, Ellis G, Herbison P, Hay-Smith J: Cochrane Database Syst Rev 2006:CD003781.
- Pais, Riona; Lee, Phillip; Cross, Shamira; Gebski, Val and Aggarwal, Rajesh. Bladder Care in Palliative Care Inpatients: A Prospective Dual Site Cohort Study. Palliative Medicine Reports 2020 1:1, 251-258.
